CXL libéré
Découvrez le futur du Cross-Linking
Type de Lampe à Fente
Pour CXL moderne:
convient aux lampes à fente de design Haag Streit et Zeiss.
Lampe à fente ou sur table
CXL Classique:
un support de table est disponible.
Protocoles intégrés
Choisissez parmi plusieurs
protocoles cliniques bien définis.
Gamme d'intensités
Délivre 3, 9, 15, 18 et 30 mW/cm².
Lumière pulsée ou continue
For various keratoconus
Pour divers paramètres de kératocônes et de kératites infectieuses.
Profil ajusté selon l'épaisseur
Beam profile delivers
Profil de faisceau fournit plus d'énergie dans la périphérie de la cornée.
Batterie de technologie supérieure
Construit pour durer des milliers de traitements.
Accessible aux fauteuils roulants
Traiter commodément les personnes en fauteuil roulant
The C-eye device is CE marked for the following indications: keratoconus, ectasia after LASIK/PRK, pellucid marginal degeneration, infectious keratitis, sterile corneal melting, bullous keratopathy. The C-eye is not available for sale in the United States.
Le dispositif C-eye d'EMAGine apporte la technologie du cross-linking à la lampe à fente. Simple, efficace et sûr, du novice à l'expert.
Effectuer le CXL à la lampe à fente ou utilisez notre périphérique C-eye comme n'importe quel autre périphérique de CXL sur une table, dans votre salle d'opération.
Travailler dans des endroits différents? Emportez l'appareil C-eye où que vous soyez. Chargez-le via USB-C, avec le chargeur de votre smartphone ou votre ordinateur portable.
Réduit le temps et les coûts liés à l'exécution du CXL
Le dispositif C-eye va révolutionner le CXL
Les 221 000 ophtalmologues sont unis par un seul équipement, la lampe à fente. Cela définit notre métier. Notre technologie offre à tous ces ophtalmologues la possibilité d'effectuer un CXL à la lampe à fente. Sans bloc opératoire. Simple. Efficace. Sûr.

Cross-linking in the
CXL au bloc opératoire
La manière classique - CXL en position couchée
Puis-je effectuer CXL dans mon bureau ?
Remember that every cross-linking procedure not only improves biomechanics, it also “disinfects” the cornea by directly killing all micro-organisms and by inhibiting cellular replication. This is why a cornea at the end of every CXL and PACK-CXL procedure is “sterile”. And by the way: office-based cataract surgery et office-based intravitreal injections have been performed in many thousands of cases without increased infection risk.
Irradiation time is not too long. Current modern protocols are integrated in the C-eye device and treat in as little as 10 minutes (CXL) and 4 minutes (PACK-CXL). See the published approach ici.
We need 3 elements for successful cross-linking: UV light, oxygen and riboflavin. Both UV light and oxygen do not “care” whether the patient is laying down or sitting. As for riboflavin, published research shows that riboflavin concentration is stable in the upright position for up to 60 minutes - much longer than we need for a CXL treatment.
Offer the patient the comfortable surgeon’s chair with the armrest and take the extra time to ensure that the patient is well-adjusted. Then, the patient is very comfortable.
Fixation is no issue. Offer the patient the fixation target that most slit lamps offer (for retinal examination) and the patient will keep a very steady fixation, as you can see ici.
Find more answers in our FAQ section.


Le dispositif C-eye convient à un certain nombre de lampes à fente de type Haag-Streit et Zeiss.

POSTS
High fluence PACK-CXL is better than low fluence PACK-CXL
Photoactivated chromophore for keratitis-corneal cross-linking (PACK-CXL) has progressed a great deal since it was first developed (1) as a treatment
CXL and Oxygen: Explaining the Relationship
EMAGine’s Chief Scientific Officer, Professor Farhad Hafezi of the ELZA Institute in Zurich, Switzerland, has prepared a presentation that provides a comprehensive overview of how oxygen concentration is at the center of all these decisions.
Digital Ophthalmology Interviews EMAGine CEO, Nikki Hafezi
Dr. Sebastian Siebelman from the media outlet, “Digital Ophthalmology” interviewed EMAGine AG’s Chief Executive Officer, Nikki Hafezi, on how she turns ideas into reality – and this includes EMAGine AG!
Landmark PACK-CXL trial published
This month, a landmark PACK-CXL trial was published that shows that PACK-CXL is an effective corneal infection therapy.
PACK-CXL as adjuvant therapy improves outcomes
“PACK-CXL is safe for use in bacterial keratitis cases. It also seems to add value in reducing healing time and improving final visual acuity while reducing the need for tectonic keratoplasty” noted the study authors.
What’s the best way to cross-link the eyes of wheelchair users?
It can be challenging to cross-link the eyes of wheelchair users – for the patient and clinic staff alike. One
What is the future of CXL?
Corneal cross-linking (CXL) has been used in the clinic for over 20 years now, but if you ever wanted to
More posts:
VIDÉOS
Webinars and congresses
Upcoming Event
janvier 21, 2022
NUHS 36th Anniversary Conference

Location: Singapore
Language: English
Upcoming Event
janvier 15, 2022
Muscat International Ophthalmology Conference (MIOC)

Location: Muscat, Oman
Language: English
Upcoming Event
décembre 4, 2021
Kölner Adventssymposium 2021

Location: Köln, Germany
Language: German
Upcoming Event
novembre 25, 2021
Middle East Africa Council of Ophthalmology

Location: Dubai, UAE
Language: English
Upcoming Event
novembre 18, 2021
14th World Down Syndrome Congress

Location: Dubai, UAE
Language: English
Upcoming Event
novembre 11, 2021
La Société Marocaine de la chirurgie réfractive

Location: Rabat, Morocco
Language: French
Upcoming Event
novembre 4, 2021
Sorocaba Eye Bank

Location: Brésil
Language: English
Upcoming Event
octobre 28, 2021
Emirates Society Of Ophthalmology

Location: Dubai, UAE
Language: English
Upcoming Event
octobre 23, 2021
LV Prasad Eye Institute

Location: Hyderabad, India
Language: English
Upcoming Event
octobre 23, 2021
65th Brazilian Congress of Ophthalmology

Location: Natal, Brazil
Language: English